LYPD3 and invasive carcinoma: Interestingly, C4.4A deficiency seemed to affect the incidence of invasive bladder carcinomas, since fewer C4.4A−/− mice (44%) developed invasive carcinomas compared to C4.4A+/+ littermates (83%).